Review Article

Tuberculosis cases comparison in developed country (Australia) and developing country (Indonesia): a comprehensive review from clinical, epidemiological, and microbiological aspects

Ni Luh Putu Harta Wedari , I Wayan Adi Pranata, Ni Nyoman Sri Budayanti, I Dewa Made Sukrama

Ni Luh Putu Harta Wedari
Clinical Microbiology Residency Program, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Bali, Indonesia. Email: hartawedari@gmail.com

I Wayan Adi Pranata
Indonesia Research Partnership on Infectious Diseases (INA-RESPOND), Jakarta, Indonesia

Ni Nyoman Sri Budayanti
Clinical Microbiology Department, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Bali, Indonesia

I Dewa Made Sukrama
Clinical Microbiology Department, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Bali, Indonesia
Online First: June 22, 2021 | Cite this Article
Harta Wedari, N., Pranata, I., Budayanti, N., Sukrama, I. 2021. Tuberculosis cases comparison in developed country (Australia) and developing country (Indonesia): a comprehensive review from clinical, epidemiological, and microbiological aspects. Intisari Sains Medis 12(2): 421-426. DOI:10.15562/ism.v12i2.1034


Background: Tuberculosis (TB) is one of most crucial public health issues around the world. TB is an entity of a complex disease with the socio-economic aspect that has very strong correlation in regard to combat this disease. Migration from developing country to developed country inevitably possesses big influence on global epidemiologic of TB. In Australia, TB still becomes the main threat not only in native population but also regarding the migrant movement into Australia. Indonesia is one of among the TB endemic countries with high TB cases, in which not merely due to its high TB prevalence and incidence but also influenced by very high and dense population.

Aim: This literature aims to review the clinical, epidemiological, and microbiological aspects of tuberculosis as a comparison between developed country (Australia) and developing country (Indonesia).

Conclusion: Tuberculosis cases in Australia remains low compared to Indonesia, however, the close proximity to adjacent developing countries with high endemic of TB contributes significantly to increase number of TB in Australia. Tuberculosis can be cured by following the treatment guidelines with proper monitoring. Moreover, the collaboration between public and private sector along with active collaboration from the family or people surrounding the patients is required to eliminate TB disease.

References

World Health Organization. Global tuberculosis report 2019. Geneva; 2019. Available at: https://www.who.int/tb/publications/global_report/en/. Accessed on 29 April 2021.

Surya A, Setyaningsih B, Nasution HS, Parwati CG, Yuzwar YE, Osberg M, Hanson CL, Hymoff A, Mingkwan P, Makayova J, Gebhard A, Waworuntu W. Quality tuberculosis care in Indonesia: using patients pathway analysis to optimize public private collaboration. Journal of Infectious Diseases. 2017;216:724-732.

Australian Government, Department of Health. Tuberculosis notifications in Australia, 2014. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cdi4103-k. Accessed on 29 April 2021.

Australian Government, Department of Home Affairs. Threats to public health. Available at: https://www.homeaffairs.gov.au/trav/visa/heal/overview-of-the-health-requirement/threats-to-public-health. Accessed on 29 April 2021.

Karyadi E, Schultink W, Nelwan RHH, Gross R, Amin Z, Dolmans WMV, Meer JWMV, Hautvast GAJ, West CE. Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia. Journal of Nutrition. 2000;130(12):2953-2958.

Parwati I, Crevel RV, Sudiro M, Alisjahbana B, Pakasi T, Kremer K, Zanden AVD, Soolingen DV. Mycobacterium tuberculosis population structures differ significantly on two Indonesia Islands. Journal of Clinical Microbiology. 2008;46(11):3639-3645.

Talbot EA, Raffa BJ. Mycobacterium tuberculosis. In Molecular Medical Microbiology, 2nd ed; Academic Press: Boston, MA, USA, 2015;3:1637-1653.

Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clinical Microbiology Reviews. 2003;16(3):463-496.

Kalscheuer R, Palacios A, Anso I, Cifuente J, Anguita J, Jacobs Jr WR, Guerin ME and Prados-Rosales R. The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis. Biochemical Journal. 2019; 476(14):1995-2016.

Sulis G, Roggi A, Matteelli A, Raviglione MC. Tuberculosis: epidemiology and control. Mediterr J Hematol Infect Dis. 2014;6(1):e2014070.

NSW Government. Tuberculosis. Available at: https://www.health.nsw.gov.au/infectious/tuberculosis/Pages/default.aspx. Accessed on 29 April 2021.

Gupta KB, Gupta R, Atreja A, Verma M, Vishvkarma S. Tuberculosis and nutrition. Lung India. 2009:26(1):9-16.

McBryde ES, Denholm JT. Risk of active tuberculosis in immigrants: effects of age, region of origin and time since arrival in low-exposure setting. The Medical Journal of Australia. 2012;197: 459-461.

Kusumawati RL, Tania T, McNeil E, Chongsuvivatwong V. Predictors of multidrug resistance among pulmonary tuberculosis patients in a tertiary hospital in North Sumatera, Indonesia. Bali Medical Journal. 2018;7(1):68-73.

Aboltins C, Lynne B, Curtis N, Darby J, Denholm J, Flynn M, Gibney K, Giles M, Graham S, Lane G, Lane D, Leslie D, Ranganathan S, Street A, Streeton J. Management, control and prevention of tuberculosis. Department of Health & Human Services, State Government of Victoria; 2015.


No Supplementary Material available for this article.
Article Views      : 81
PDF Downloads : 44